Hudson Bay Capital Management LP

Position in IMCR — Immunocore Holdings plc

CIK 1393825 STAMFORD, CT

Position in IMCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,732,500

-$357,696 QoQ

Shares Held

590,000

-6.8% QoQ

Ownership

1.15%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#22

of 136 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. IMCR ranks #5 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	390,440	$193,943,261
2	BMRN	Biomarin Pharmaceutical Inc	825,002	$47,206,614
3	ALNY	Alnylam Pharmaceuticals, Inc.	148,720	$44,769,181
4	BNTX	BioNTech SE	260,000	$24,193,000
5	IMCR	Immunocore Holdings plc This page	590,000	$18,732,500
6	TECH	BIO-TECHNE Corp	200,000	$14,130,000
7	VIR	Vir Biotechnology, Inc.	1,364,000	$13,899,160
8	PTCT	Ptc Therapeutics, Inc.	159,778	$13,033,091

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,732,500	590,000	-6.8%	Shares	Sole	2026-08-14
2026-03-31	$19,090,196	633,174	+65.1%	Shares	Sole	2026-05-13
2025-12-31	$13,313,298	383,558	+15.0%	Shares	Sole	2026-02-13
2025-09-30	$12,118,162	333,558	-3.6%	Shares	Sole	2025-12-15
2025-06-30	$10,855,973	345,952	-12.5%	Shares	Sole	2025-08-18
2025-03-31	$11,729,559	395,334	+21.5%	Shares	Sole	2025-05-14
2024-12-31	$9,596,350	325,300	+31.5%	Shares	Sole	2025-02-14
2024-09-30	$7,698,449	247,300	+28.0%	Shares	Sole	2024-11-13
2024-06-30	$6,546,836	193,179	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.